Similar articles

• [Current management of adult acute lymphoblastic leukemia/lymphoma].

  Usui N. Usui N. Rinsho Ketsueki. 2011 Oct;52(10):1594-602. Rinsho Ketsueki. 2011. PMID: 21971236 Review. Japanese. No abstract available.
• [Use of monoclonal antibodies in acute lymphoblastic leukemia in children. II. Clinical picture and prognosis in specific immunological subgroups].

  Kołecki P, Radwańska U. Kołecki P, et al. Pediatr Pol. 1988 Nov;63(11):698-702. Pediatr Pol. 1988. PMID: 3253656 Polish. No abstract available.
• Cytoreduction and prognosis in childhood acute lymphoblastic leukemia.

  Aricò M, Masera G. Aricò M, et al. J Clin Oncol. 1997 Mar;15(3):1285. J Clin Oncol. 1997. PMID: 9060574 No abstract available.
• Nelarabine for the treatment of patients with relapsed or refractory T-cell acute lymphoblastic leukemia or lymphoblastic lymphoma.

  DeAngelo DJ. DeAngelo DJ. Hematol Oncol Clin North Am. 2009 Oct;23(5):1121-35, vii-viii. doi: 10.1016/j.hoc.2009.07.008. Hematol Oncol Clin North Am. 2009. PMID: 19825456 Review.
• Rituximab as therapy for acute lymphoblastic leukemia.

  Thomas DA. Thomas DA. Clin Adv Hematol Oncol. 2010 Mar;8(3):168-71. Clin Adv Hematol Oncol. 2010. PMID: 20400931 No abstract available.